1. Home
  2. ADVM vs MAXN Comparison

ADVM vs MAXN Comparison

Compare ADVM & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • MAXN
  • Stock Information
  • Founded
  • ADVM 2006
  • MAXN 2019
  • Country
  • ADVM United States
  • MAXN Singapore
  • Employees
  • ADVM N/A
  • MAXN N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • MAXN Semiconductors
  • Sector
  • ADVM Health Care
  • MAXN Technology
  • Exchange
  • ADVM Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • ADVM 47.4M
  • MAXN 56.0M
  • IPO Year
  • ADVM 2014
  • MAXN N/A
  • Fundamental
  • Price
  • ADVM $2.39
  • MAXN $3.87
  • Analyst Decision
  • ADVM Strong Buy
  • MAXN Sell
  • Analyst Count
  • ADVM 5
  • MAXN 1
  • Target Price
  • ADVM $23.80
  • MAXN $4.00
  • AVG Volume (30 Days)
  • ADVM 122.9K
  • MAXN 202.3K
  • Earning Date
  • ADVM 08-11-2025
  • MAXN 09-02-2025
  • Dividend Yield
  • ADVM N/A
  • MAXN N/A
  • EPS Growth
  • ADVM N/A
  • MAXN N/A
  • EPS
  • ADVM N/A
  • MAXN N/A
  • Revenue
  • ADVM $1,000,000.00
  • MAXN $509,048,000.00
  • Revenue This Year
  • ADVM N/A
  • MAXN $100.37
  • Revenue Next Year
  • ADVM $18.82
  • MAXN $24.61
  • P/E Ratio
  • ADVM N/A
  • MAXN N/A
  • Revenue Growth
  • ADVM N/A
  • MAXN N/A
  • 52 Week Low
  • ADVM $1.78
  • MAXN $2.49
  • 52 Week High
  • ADVM $8.56
  • MAXN $23.11
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 42.53
  • MAXN 49.28
  • Support Level
  • ADVM $2.61
  • MAXN $4.28
  • Resistance Level
  • ADVM $2.82
  • MAXN $4.97
  • Average True Range (ATR)
  • ADVM 0.21
  • MAXN 0.47
  • MACD
  • ADVM -0.03
  • MAXN 0.00
  • Stochastic Oscillator
  • ADVM 8.57
  • MAXN 37.85

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: